Cargando…
Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy
Chemotherapy-induced peripheral neuropathy is a very frequent neurological complication in cancer. Oxaliplatin (OXA) is a platinum analogue used as a first-line agent in the treatment of colorectal cancer. OXA induced peripheral neuropathy (OIN) is the main toxicity both during and after the complet...
Autores principales: | Bruna, Jordi, Velasco, Roser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998628/ https://www.ncbi.nlm.nih.gov/pubmed/29862996 http://dx.doi.org/10.4103/1673-5374.232459 |
Ejemplares similares
-
Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015) -
Discovery of Potential
Neuroprotective Agents against
Paclitaxel-Induced Peripheral Neuropathy
por: Chen, Yi-Fan, et al.
Publicado: (2022) -
Peripheral neuropathies associated with DNA repair disorders
por: Maguina, Melissa, et al.
Publicado: (2022) -
Neuroprotective effects of statins against amyloid β-induced neurotoxicity
por: Li, Hsin-Hua, et al.
Publicado: (2018) -
TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy
por: Marcotti, Aida, et al.
Publicado: (2022)